PortfoliosLab logoPortfoliosLab logo
ZEAL.CO vs. NKT.CO
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

ZEAL.CO vs. NKT.CO - Performance Comparison

The chart below illustrates the hypothetical performance of a DKK 10,000 investment in Zealand Pharma A/S (ZEAL.CO) and NKT A/S (NKT.CO). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, ZEAL.CO achieves a -36.58% return, which is significantly lower than NKT.CO's 22.79% return. Over the past 10 years, ZEAL.CO has underperformed NKT.CO with an annualized return of 10.55%, while NKT.CO has yielded a comparatively higher 21.65% annualized return.


ZEAL.CO

1D
0.51%
1M
-4.76%
YTD
-36.58%
6M
-39.98%
1Y
-37.65%
3Y*
2.31%
5Y*
8.36%
10Y*
10.55%

NKT.CO

1D
-0.15%
1M
-7.15%
YTD
22.79%
6M
23.26%
1Y
82.25%
3Y*
33.49%
5Y*
31.24%
10Y*
21.65%
*Multi-year figures are annualized to reflect compound growth (CAGR)

ZEAL.CO vs. NKT.CO - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
ZEAL.CO
Zealand Pharma A/S
-36.58%-34.81%91.72%85.30%38.80%-34.22%-6.29%185.68%-3.06%-20.19%
NKT.CO
NKT A/S
22.79%55.20%10.93%29.04%24.02%16.37%90.92%80.78%-68.60%14.20%

Correlation

The correlation between ZEAL.CO and NKT.CO is 0.30, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.30

Correlation (3Y)
Calculated over the trailing 3-year period

0.24

Correlation (5Y)
Calculated over the trailing 5-year period

0.28

Correlation (10Y)
Calculated over the trailing 10-year period

0.27

Correlation (All Time)
Calculated using the full available price history since Nov 23, 2010

0.25

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

ZEAL.CO vs. NKT.CO — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ZEAL.CO
ZEAL.CO Risk / Return Rank: 1818
Overall Rank
ZEAL.CO Sharpe Ratio Rank: 1818
Sharpe Ratio Rank
ZEAL.CO Sortino Ratio Rank: 2323
Sortino Ratio Rank
ZEAL.CO Omega Ratio Rank: 2222
Omega Ratio Rank
ZEAL.CO Calmar Ratio Rank: 1818
Calmar Ratio Rank
ZEAL.CO Martin Ratio Rank: 99
Martin Ratio Rank

NKT.CO
NKT.CO Risk / Return Rank: 9292
Overall Rank
NKT.CO Sharpe Ratio Rank: 9191
Sharpe Ratio Rank
NKT.CO Sortino Ratio Rank: 9292
Sortino Ratio Rank
NKT.CO Omega Ratio Rank: 8888
Omega Ratio Rank
NKT.CO Calmar Ratio Rank: 9595
Calmar Ratio Rank
NKT.CO Martin Ratio Rank: 9595
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ZEAL.CO vs. NKT.CO - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Zealand Pharma A/S (ZEAL.CO) and NKT A/S (NKT.CO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


ZEAL.CONKT.CODifference
Sharpe ratioReturn per unit of total volatility

-2.83

Sortino ratioReturn per unit of downside risk

-3.71

Omega ratioGain probability vs. loss probability

0.94

1.38

-0.44

Calmar ratioReturn relative to maximum drawdown

-0.67

6.31

-6.98

Martin ratioReturn relative to average drawdown

-1.39

18.57

-19.96

ZEAL.CO vs. NKT.CO - Sharpe Ratio Comparison

The current ZEAL.CO Sharpe Ratio is -0.55, which is lower than the NKT.CO Sharpe Ratio of 2.28. The chart below compares the historical Sharpe Ratios of ZEAL.CO and NKT.CO, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

ZEAL.CO vs. NKT.CO - Drawdown Comparison

The maximum ZEAL.CO drawdown since its inception was -75.53%, smaller than the maximum NKT.CO drawdown of -85.84%. Use the drawdown chart below to compare losses from any high point for ZEAL.CO and NKT.CO.


Loading charts...

Drawdown Indicators


ZEAL.CONKT.CODifference

Max Drawdown

Largest peak-to-trough decline

-75.53%

-85.84%

+10.31%

Max Drawdown (1Y)

Largest decline over 1 year

-56.96%

-13.31%

-43.65%

Max Drawdown (3Y)

Largest decline over 3 years

-75.38%

-34.39%

-40.99%

Max Drawdown (5Y)

Largest decline over 5 years

-75.38%

-34.39%

-40.99%

Max Drawdown (10Y)

Largest decline over 10 years

-75.53%

-74.42%

-1.11%

Current Drawdown

Current decline from peak

-68.99%

-11.83%

-57.16%

Average Drawdown

Average peak-to-trough decline

-30.90%

-30.37%

-0.53%

Ulcer Index

Depth and duration of drawdowns from previous peaks

28.60%

4.58%

+24.02%

Volatility

ZEAL.CO vs. NKT.CO - Volatility Comparison

Zealand Pharma A/S (ZEAL.CO) has a higher volatility of 32.28% compared to NKT A/S (NKT.CO) at 11.51%. This indicates that ZEAL.CO's price experiences larger fluctuations and is considered to be riskier than NKT.CO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


ZEAL.CONKT.CODifference

Volatility (1M)

Calculated over the trailing 1-month period

32.28%

11.51%

+20.77%

Volatility (6M)

Calculated over the trailing 6-month period

63.18%

23.53%

+39.65%

Volatility (1Y)

Calculated over the trailing 1-year period

69.18%

36.90%

+32.28%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

61.52%

36.57%

+24.95%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

52.84%

40.60%

+12.24%

Dividends

ZEAL.CO vs. NKT.CO - Dividend Comparison

Neither ZEAL.CO nor NKT.CO has paid dividends to shareholders.


PositionTTM20252024202320222021202020192018201720162015
NKT.CO
NKT A/S
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%1.42%2.25%
ZEAL.CO
Zealand Pharma A/S
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Financials

ZEAL.CO vs. NKT.CO - Financials Comparison

This section allows you to compare key financial metrics between Zealand Pharma A/S and NKT A/S. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in DKK except per share items

Frequently Asked Questions


ZEAL.CO and NKT.CO have a correlation of 0.30, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Portfolio Optimizer

Find the right allocation for ZEAL.CO and NKT.CO

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer